Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Traynor

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
British Journal of Pharmacology|July 1, 1979
Effects of antimalarial drugs on phospholipase A2 [proceedings]K S Authi, J R Traynor
Neuropeptides|December 1, 1984
Opiate binding in the rat spinal cord: evidence for mu and delta sitesJ R Traynor, M J Rance
The Journal of Pharmacy and Pharmacology|November 1, 1982
Stimulation of polymorphonuclear leucocyte phospholipase A2 activity by chloroquine and mepacrineK S Authi, J R Traynor
Neuropeptides|November 1, 1987
Distribution of opioid binding sites in spinal cordJ R Traynor, M S Wood
The Journal of Applied Bacteriology|November 1, 1986
The action of various venoms on Escherichia coliJ F Stocker, J R Traynor
British Journal of Pharmacology|March 1, 1991
Alkylation with beta-funaltrexamine suggests differences between mu-opioid receptor systems in guinea-pig brain and myenteric-plexusT G Franklin, J R Traynor
Molecular Pharmacology|April 1, 1995
Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cellsJ R Traynor, S R Nahorski
Progress in Clinical and Biological Research|January 1, 1990
Characterisation of opioid binding sites using selective antagonistsA J Lawrence, J R Traynor
British Journal of Pharmacology|November 1, 1990
Evidence that the agonist action of dynorphin A(1-8) in the guinea-pig myenteric-plexus may be mediated partly through conversion to [Leu5]enkephalinD M Dixon, J R Traynor
Canadian Journal of Physiology and Pharmacology|July 23, 1998
Dynorphin A(1-8): stability and implications for in vitro opioid activityK M Bell, J R Traynor
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
British Journal of Pharmacology|July 1, 1979
Effects of antimalarial drugs on phospholipase A2 [proceedings]K S Authi, J R Traynor
Neuropeptides|December 1, 1984
Opiate binding in the rat spinal cord: evidence for mu and delta sitesJ R Traynor, M J Rance
The Journal of Pharmacy and Pharmacology|November 1, 1982
Stimulation of polymorphonuclear leucocyte phospholipase A2 activity by chloroquine and mepacrineK S Authi, J R Traynor
Neuropeptides|November 1, 1987
Distribution of opioid binding sites in spinal cordJ R Traynor, M S Wood
The Journal of Applied Bacteriology|November 1, 1986
The action of various venoms on Escherichia coliJ F Stocker, J R Traynor
British Journal of Pharmacology|March 1, 1991
Alkylation with beta-funaltrexamine suggests differences between mu-opioid receptor systems in guinea-pig brain and myenteric-plexusT G Franklin, J R Traynor
Molecular Pharmacology|April 1, 1995
Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cellsJ R Traynor, S R Nahorski
Progress in Clinical and Biological Research|January 1, 1990
Characterisation of opioid binding sites using selective antagonistsA J Lawrence, J R Traynor
British Journal of Pharmacology|November 1, 1990
Evidence that the agonist action of dynorphin A(1-8) in the guinea-pig myenteric-plexus may be mediated partly through conversion to [Leu5]enkephalinD M Dixon, J R Traynor
Canadian Journal of Physiology and Pharmacology|July 23, 1998
Dynorphin A(1-8): stability and implications for in vitro opioid activityK M Bell, J R Traynor
Pageof 9